Trial · NCT04058366
Results by group14
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 14 of 14
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Part A: Safety and Tolerability as Assessed by Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) | Part A: ELX/TEZ/IVA | Participants with TEAEs | 241 | Participants | |
| Part A: Safety and Tolerability as Assessed by Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs) | Part A: ELX/TEZ/IVA | Participants with SAEs | 38 | Participants | |
| Part A: Absolute Change From Parent Study Baseline in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1) | ELX/TEZ/IVA | Control-IVA or TEZ/IVA: Change at Week 96 | 4.1 | 95% Confidence Interval 2.5 to 5.7 | percentage points |
| Part A: Absolute Change From Parent Study Baseline in Percent Predicted Forced Expiratory Volume in 1 Second (ppFEV1) | ELX/TEZ/IVA | ELX/TEZ/IVA: Change at Week 96 | 3.7 | 95% Confidence Interval 2.2 to 5.2 | percentage points |
| Part A: Absolute Change From Parent Study Baseline in Sweat Chloride (SwCl) | ELX/TEZ/IVA | Control-IVA or TEZ/IVA: Change at Week 96 | -23.0 | 95% Confidence Interval -25.8 to -20.1 | millimole per liter (mmol/L) |
| Part A: Absolute Change From Parent Study Baseline in Sweat Chloride (SwCl) | ELX/TEZ/IVA | ELX/TEZ/IVA: Change at Week 96 | -22.6 | 95% Confidence Interval -25.4 to -19.9 | millimole per liter (mmol/L) |
| Part A: Absolute Change From Parent Study Baseline in Body Mass Index (BMI) | ELX/TEZ/IVA | Control-IVA or TEZ/IVA: Change at Week 96 | 1.15 | 95% Confidence Interval 0.84 to 1.45 | kg/m^2 |
| Part A: Absolute Change From Parent Study Baseline in Body Mass Index (BMI) | ELX/TEZ/IVA | ELX/TEZ/IVA: Change at Week 96 | 0.83 | 95% Confidence Interval 0.54 to 1.11 | kg/m^2 |
| Part A: Absolute Change From Parent Study Baseline in BMI Z-score | ELX/TEZ/IVA | Control-IVA or TEZ/IVA: Change at Week 96 | 0.11 | 95% Confidence Interval -0.17 to 0.40 | z-score |
| Part A: Absolute Change From Parent Study Baseline in BMI Z-score | ELX/TEZ/IVA | ELX/TEZ/IVA: Change at Week 96 | 0.40 | 95% Confidence Interval 0.17 to 0.62 | z-score |
| Part A: Absolute Change From Parent Study Baseline in Body Weight | ELX/TEZ/IVA | Control-IVA or TEZ/IVA: Change at Week 96 | 3.6 | 95% Confidence Interval 2.7 to 4.6 | Kilogram (Kg) |
| Part A: Absolute Change From Parent Study Baseline in Body Weight | ELX/TEZ/IVA | ELX/TEZ/IVA: Change at Week 96 | 2.9 | 95% Confidence Interval 2.0 to 3.8 | Kilogram (Kg) |
| Part A: Absolute Change From Parent Study Baseline in Cystic Fibrosis Questionnaire-Revised (CFQ-R) Respiratory Domain Score | ELX/TEZ/IVA | Control-IVA or TEZ/IVA: Change at Week 96 | 7.2 | 95% Confidence Interval 4.1 to 10.4 | units on a scale |
| Part A: Absolute Change From Parent Study Baseline in Cystic Fibrosis Questionnaire-Revised (CFQ-R) Respiratory Domain Score | ELX/TEZ/IVA | ELX/TEZ/IVA: Change at Week 96 | 8.1 | 95% Confidence Interval 5.1 to 11.1 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04058366/results